GOLDMAN SACHS GROUP INC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$400,943
+23.2%
153,618
+69.0%
0.00%
Q2 2023$325,476
+47.9%
90,915
-9.9%
0.00%
Q1 2023$220,080
+10.8%
100,954
+511.6%
0.00%
Q4 2022$198,579
-44.1%
16,507
-69.9%
0.00%
Q3 2022$355,000
+173.1%
54,902
+93.6%
0.00%
Q2 2022$130,000
-78.6%
28,363
-59.6%
0.00%
Q1 2022$607,000
-63.7%
70,183
-40.0%
0.00%
Q4 2021$1,672,000
+284.4%
117,034
+492.0%
0.00%
Q3 2021$435,000
-7.2%
19,768
-43.6%
0.00%
Q2 2021$469,000
+133.3%
35,055
+77.4%
0.00%
Q1 2021$201,00019,7550.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders